Literature DB >> 15258722

Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.

Simon D Roe1, Christine J Porter, Ian M Godber, David J Hosking, Michael J Cassidy.   

Abstract

BACKGROUND: Osteoporosis is increasingly recognized as a major source of morbidity following renal transplantation. The aim of this cross-sectional study was to determine the prevalence of osteoporosis in a cohort of male transplant recipients and examine factors that may influence their bone loss.
METHODS: Bone mineral density (BMD) and biochemical markers of bone metabolism were measured in 134 out of 154 male renal allograft recipients in our center.
RESULTS: The mean age of the patients was 49.7 years (range 26-76) with a median of 6 years post-transplant. Only 17% had normal BMD, 30% were osteoporotic at either hip or spine, and this proportion rose to 41% if the ultradistal radius was included. Parathyroid hormone (PTH) was negatively correlated with BMD at all skeletal sites. In a multiple regression model, independent predictors of femoral neck BMD included body mass index (p=0.004), diabetes (p=0.025), and PTH (p=0.049). The only independent predictor of BMD at the ultradistal radius was PTH (p<0.001). Nineteen men sustained a total of 25 appendicular fractures after transplantation (median time to fracture was 3 years). Prevalent vertebral fractures were only identified in five men. PTH was elevated in 72.4% of patients (mean PTH 142 +/- 118 pg/ml). Bone resorption markers were increased in 48% of patients. PTH was positively correlated with serum carboxyterminal telopeptide of type 1 collagen (r=0.473, p<0.001) and procollagen type 1 amino terminal propeptide (r=0.419, p<0.001).
CONCLUSIONS: Osteopenia and osteoporosis are common in male transplant recipients, and the hip and radius are the most severely affected sites. Elevated rates of bone resorption driven by hyperparathyroidism appear to be the most important contributing factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258722     DOI: 10.1007/s00198-004-1653-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  19 in total

Review 1.  Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton.

Authors:  S Epstein
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

2.  Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.

Authors:  D N Cruz; J J Wysolmerski; H M Brickel; C G Gundberg; C A Simpson; M A Mitnick; A S Kliger; M I Lorber; G P Basadonna; A L Friedman; K L Insogna; M J Bia
Journal:  Transplantation       Date:  2001-07-15       Impact factor: 4.939

3.  Factors involved in the loss of bone mineral density after renal transplantation.

Authors:  J V Torregrosa; J M Campistol; M Montesinos; B Fenollosa; F Pons; M J Martinez de Osaba; F Oppenheimer
Journal:  Transplant Proc       Date:  1995-08       Impact factor: 1.066

4.  No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.

Authors:  G Dumoulin; B Hory; N U Nguyen; C Bresson; V Fournier; M Bouhaddi; J M Chalopin; Y Saint-Hillier; J Regnard
Journal:  Am J Kidney Dis       Date:  1997-05       Impact factor: 8.860

5.  Increased fracture rate in diabetes mellitus and females after renal transplantation.

Authors:  U Nisbeth; E Lindh; S Ljunghall; U Backman; B Fellström
Journal:  Transplantation       Date:  1999-05-15       Impact factor: 4.939

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Risk factors for reduced bone density in haemodialysis patients.

Authors:  M W Taal; T Masud; D Green; M J Cassidy
Journal:  Nephrol Dial Transplant       Date:  1999-08       Impact factor: 5.992

8.  Increased risk of fracture in patients receiving solid organ transplants.

Authors:  R Ramsey-Goldman; J E Dunn; D D Dunlop; F P Stuart; M M Abecassis; D B Kaufman; C B Langman; M H Salinger; S M Sprague
Journal:  J Bone Miner Res       Date:  1999-03       Impact factor: 6.741

9.  Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients.

Authors:  W H Grotz; F A Mundinger; B Gugel; V Exner; G Kirste; P J Schollmeyer
Journal:  Transplantation       Date:  1994-10-27       Impact factor: 4.939

10.  Rapid loss of vertebral mineral density after renal transplantation.

Authors:  B A Julian; D A Laskow; J Dubovsky; E V Dubovsky; J J Curtis; L D Quarles
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

View more
  12 in total

1.  Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation.

Authors:  Ana Rocha; La Salete Martins; Jorge Malheiro; Jorge Dores; Clara Santos; Castro Henriques
Journal:  J Bone Miner Metab       Date:  2015-04-03       Impact factor: 2.626

2.  Influence of corticosteroids on QUS parameters of the calcaneus in the 1st year after renal transplantation: comment.

Authors:  P Adamczyk
Journal:  Osteoporos Int       Date:  2006       Impact factor: 4.507

Review 3.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

4.  Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.

Authors:  Vincent M Brandenburg; Markus Ketteler; Nicole Heussen; Dirk Politt; Rolf D Frank; Ralf Westenfeld; Thomas H Ittel; Jürgen Floege
Journal:  Osteoporos Int       Date:  2005-07-06       Impact factor: 4.507

5.  Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients.

Authors:  Steven W Ing; Loraine T Sinnott; Sirisha Donepudi; Elizabeth A Davies; Ronald P Pelletier; Nancy E Lane
Journal:  Clin Transplant       Date:  2010-10-21       Impact factor: 2.863

Review 6.  Osteoporosis in patients with diabetes after kidney transplantation.

Authors:  Elvira O Gosmanova; Aidar R Gosmanov
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 7.  Bone Mineral Disease After Kidney Transplantation.

Authors:  Josep-Vicent Torregrosa; Ana Carina Ferreira; David Cucchiari; Aníbal Ferreira
Journal:  Calcif Tissue Int       Date:  2021-03-25       Impact factor: 4.333

8.  Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats.

Authors:  T Matsunaga; M Shigetomi; T Hashimoto; H Suzuki; T Gondo; H Tanaka; T Sugiyama; T Taguchi
Journal:  Osteoporos Int       Date:  2007-05-10       Impact factor: 4.507

9.  Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients.

Authors:  Africa Muxí; José-Vicente Torregrosa; David Fuster; Pilar Peris; Sergi Vidal-Sicart; Oriol Solá; Beatriz Domenech; Gloria Martín; Joan Casellas; Francisca Pons
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

10.  Musculoskeletal affections among kidney recipients: prevalence and risk predictors.

Authors:  Alia M Atallah; Seif M Farag; Mohamed K Senna; Mohamed A Ghoneim
Journal:  Rheumatol Int       Date:  2008-04-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.